![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Simvastatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-298 - Rev 00
This Chemical Type CEP, issued on October 08, 2012, remains in force until September 13, 2017, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes